A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/185, 167/199
A61K 31/405 (2006.01) A61K 9/00 (2006.01) A61K 31/19 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2013188
Stable, clear, antimicrobially effective, ophthalmic formulations are disclosed which provide an antimicrobially effective preservative. The formulations include an ophthalmologically effective amount of a drug, which is a -COON group-containing non-steroidal anti-inflammatory drug (NSAID) in combination with an antibiotic drug, and a preservative system formed of a quaternary ammonium preservative and a nonionic polyoxyethylated octylphenol surfactant, all in an aqueous vehicle. The preservative system can be used with other formulations which require the preservative to be ophthamologically acceptable and antimicrobially effective. These formulations are useful for treating diseases and/or conditions that are either caused by, associated with or accompanied by inflammatory processes, including, among others, glaucoma, cystoid macular edema, uveitis, diabetic retinopathy and conjunctivitis, or any trauma caused by eye surgery or eye injury. The ophthalmologically acceptable antibiotic is preferably tobramycin which has been found not to interfere with the rate of diffusion of the NSAID. The combination of the NSAID and antibiotic is particularly effective in simultaneously preventing and/or eliminating infection while preventing and/or eliminating inflammation.
Fu Cherng-Chyi Roger
Lidgate Deborah M.
Dennison Associates
Syntex (u.s.a.) Inc.
Syntex (u.s.a.) Llc.
LandOfFree
Preservative system for ophthalmic formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preservative system for ophthalmic formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preservative system for ophthalmic formulations will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1420988